Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD

Summary

This study will evaluate the efficacy and safety of DA-1229 in patients with calcific aortic valve disease.

Timeline

Start

2019-08-26

Primary completion

2023-02-01

Completion

2023-02-01

Publications

• Song JK, Lee S, Kim YJ, Kim HK, Ha JW, Choi EY, Park SW, Park SJ, Park YH, Park JH, Yang DH, Kim KH, Yang DH, Han S, Chae SY, Lee JS, Song JM, Cho GY. Effect of Evogliptin on the Progression of Aortic Valvular Calcification. J Am Coll Cardiol. 2024 Sep 17;84(12):1064-1075. doi: 10.1016/j.jacc.2024.06.037.

Drugs

Indications